World Parkinson Congress Blog

The Promise of New Technologies in Research

by Christopher G. Sinon, PhD and Stella M. Papa, MD

Onsens and Other Kyoto Musings

by Binit B. Shah MD

Clinical ScienceBinit B. Shah MDMarch 16, 2020World Parkinson Congress, Kyoto, fourComment

Can we use drugs that Modulate the Renin-Angiotensin system to treat Parkinson's disease?

by Santiago Perez Lloret, MD, PhD, Matilde Otero-Losada, PhD, Lucas Udovin, PhD Francisco Capani, MD, PhD

Going against the Grain

by Suketu M. Khandhar, MD

Clinical ScienceSuketu M. Khandhar, MDFebruary 10, 2020Parkinson, fourComment

Why dyskinesias are a research priority in PD

by M. Angela Cenci Nilsson, MD, PhD

Clinical ScienceAngela Cenci NilssonFebruary 3, 2020research, Dyskinesia, fourComment

To tell or not to tell… Talking to children and grandchildren about Parkinson’s disease

by Elaine Book MSW, RSW

Clinical ScienceElaine Book MSW, RSWJanuary 27, 2020parkinsons, children, fourComment

Palliative (And End of Life) Care

by Victor M McConvey, RN, MACN

Clinical ScienceVictor McConveyJanuary 21, 2020parkinsons, Palliative Care, fourComment

Parkinson's disease in the Asia-Pacific region

by Shen-Yang Lim, MD, FRACP

Clinical ScienceShen-Yang Lim, MD FRACPJanuary 13, 2020parkinsons, asia, pacific, fourComment

Speech Therapy: You regained It, don’t forget to maintain It!

by Jennifer Cody, MS, CCC-SLP

Disease Modifying Trials

by Simon Lewis, MB, BCh, BSc, MD

Clinical ScienceSimon LewisDecember 11, 2019Parkinson's, Clinical Trials, Disease Progression, study, four Comment

Getting a grip on anxiety in PD

by Roseanne D. Dobkin, PhD and Lauren St. Hill

Clinical ScienceBrittany MartiNovember 25, 2019four, anxiety, Parkinson's Comments

Interpersonal, Intrapersonal, and Organizational Intersections: A Socio-Ecological Discussion of Adapted Tango Dance for People with Parkinson’s Disease

by Madeleine E. Hackney, PhD with Allison Bay, MPH

Clinical ScienceBrittany MartiNovember 15, 2019four, danceComment

Perspectives on the future of technologies in the care of Parkinson’s disease

by Walter Maetzler, MD and Alberto J Espay, MD

Image courtesy of Neurogeriatrics Kiel

Looking behind the masked face... Depression in Parkinson's disease

by Murat Emre, M.D.

Clinical ScienceMurat Emre, M.D.October 31, 2019parkinsons, Parkinson, Depression, four Comment

Can wearable technology improve clinic visits or clinical trials?

by Corinne Jones, PhD, CCC-SLP

Apathy: A very debilitating behavioral disorder that many patients with Parkinson’s disease have to face

By Kathy Dujardin, PhD

Clinical ScienceKathy Dujardin, PhDSeptember 13, 2019Parkinson's, four Comments

Is there any future in the use of growth factors to repair the brain in Parkinson’s disease?

Roger A Barker, MRCP PhD FMedSci

Clinical ScienceRoger Barker PhD MRCPAugust 20, 2019Parkinson's Disease, GDNF, Clinical Trials, fourComment

Falls in Parkinson's: Are we winning?

By Lynn Rochester, PhD

Clinical ScienceLynn Rochester, PhDDecember 10, 2018Parkinson's, fall prevention, four Comments

Where are we with surgery for PD?

By Elena Moro MD, PhD

Clinical ScienceElena Moro, MD, PhDDecember 3, 2018Parkinson's, four Comments

The Difference Between Parkinson's Disease and Lewy Body Dementia

by Simon JG Lewis

Clinical ScienceSimon LewisNovember 13, 2018threeComment